Interested in working with us? Call us on 800.934.1020 or fill out this quick form and we will contact you within 24 hours!



FDA OKs Treatment For C. Difficile Infection


The U.S. Food and Drug Administration has approved Dificid tablets for the treatment of Clostridium difficile-associated diarrhea.

Clostridium difficile (C. difficile) is a bacterium that can cause diarrhea and lead to colitis, other serious intestinal conditions, and death in severe cases. C. difficile bacteria are found in the stool of an infected person, and others can become infected if they touch items or surfaces contaminated with the bacteria or spores and then touch their mouths.

People at risk of developing the bacterial infection include the elderly, patients in hospitals or nursing homes, and people taking antibiotics for another infection. The most effective way to prevent this is thorough handwashing with soap and warm water.

The safety and efficacy of Dificid were demonstrated in two trials that included 564 patients with Clostridium difficile-associated diarrhea (CDAD) that compared Dificid with vancomycin, a common antibiotic used to treat CDAD.

The clinical response was similar in the Dificid group compared with the vancomycin group in both studies. In some patients with CDAD, symptoms can return. In the Dificid trials, a greater number of patients treated with Dificid had a sustained cure three weeks after treatment ended versus those patients treated with vancomycin.

“In recent years, many in the infectious disease community have seen an increase in the number of cases of people with a C. difficile infection,” said Dr. Edward Cox, director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research, in a press release. “Dificid is an effective new treatment option for patients who develop Clostridium difficile-associated diarrhea.”

Dificid, a macrolide antibacterial, should be taken two times a day for 10 days with or without food.

To maintain the effectiveness of Dificid, and to reduce the development of drug-resistant bacteria, the drug should be used only to treat infections that are proven or strongly suspected to be caused by C. difficile.

The most common side effects reported with Dificid included nausea, vomiting, headache, abdominal pain, and diarrhea.Dificid was developed by San Diego-based Optimer Pharmaceuticals Inc.

For more on nursing home health issues, see the library of articles by Daytona Beach nursing home injury attorney.



Learn more about finding and hiring a good lawyer.
Order your FREE BOOK today.

Get more information on Nursing Home Abuse in our firm's library.

Bedsores
Preventing Falls
Dangerous Nursing Home Practices
C-Diff Infection Causes Death
Nursing Homes On The Watch List


Contact Zimmet & Quarles for your FREE BOOK.


Get Free Books

See All Books

Your Questions Answered

First Name *

Last Name *

Email *

Phone

Tell Us More


Zimmet & Quarles. P.L.
Halifax Harbor Marina
125 Basin Street, Suite 210
Daytona Beach, FL 32114
Phone: (386) 255-4020
Fax: (386) 255-2027
Toll Free: (800) 934-1020
Get Directions

Offices

Zimmet & Quarles. P.L.
Halifax Harbor Marina
125 Basin Street, Suite 210
Daytona Beach, FL 32114
Phone: (386) 255-4020
Fax: (386) 255-2027
Toll Free: (800) 934-1020

find us on facebook